Clinical Trial Detail

NCT ID NCT04443348
Title Pre-op Pembro + Radiation Therapy in Breast Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alice Ho
Indications

Her2-receptor negative breast cancer

triple-receptor negative breast cancer

Therapies

Pembrolizumab

Cyclophosphamide + Doxorubicin + Paclitaxel + Pembrolizumab

Carboplatin + Cyclophosphamide + Doxorubicin + Paclitaxel + Pembrolizumab

Age Groups: adult senior

No variant requirements are available.